| Product Name |
Fulvestrant Inhouse Impurity 8 / (8R,8'R,9S,9'S,13S,13'S,14S,14'S,17S,17'S)-nonane-1,9-diylbis(3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-7,17-diyl) diacetate
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals |
| CAS No |
N/A |
| Catalog Number |
GS.47.FUL.38 |
| Chemical Name/Synonyms |
(8R,8'R,9S,9'S,13S,13'S,14S,14'S,17S,17'S)-nonane-1,9-diylbis(3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-7,17-diyl) diacetate |
| Molecular Weight |
753.08 |
| Molecular Formula |
C49H68O6 |
| Purity |
NLT 95 % |
| Applications |
Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women. |
| Inventory Status |
customized
|
